Mulsevo
Negative overtures persuade Sanofi to withdraw drug filing
July 10, 2012Sales and Marketing EMA, Mulsevo, Sanofi, blood clots, withdrawal
Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
